World News
FDA approves landmark pancreatic cancer drug that’s shown to improve survival – AP News
- FDA approves landmark pancreatic cancer drug that’s shown to improve survival AP News
- F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer The New York Times
- Stage 4 Maine cancer patient says new FDA-approved pill is buying him time WGME
- FDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease WSJ
- FDA Approves RASONQUE™ (daraxonrasib) Pancreatic Cancer Action Network